Erlotiniblet) Side Effects
View Community-reported Erlotiniblet) side effects
Add Your Side Effect to the Community Database
Help Community - Describe Your Erlotiniblet) Side Effect
Have You dealt with a Erlotiniblet) side effect? Share your experience
Erlotiniblet) Side Effects submitted to FDA
Total Erlotiniblet) reports: 3.Erlotiniblet) FDA safety alerts: No.
Reported hospitalizations: 3.
Take Erlotiniblet) Side Effects Survey, Discuss Erlotiniblet) with others
FDA Reported Erlotiniblet) Side Effects: hypernatraemia, fatigue, dehydration, blood urea increased, blood creatinine increased, blood chloride increased, blood calcium decreased, asthenia, anorexia, pyrexia, protein total decreased,
More About Erlotiniblet).
If you have questions about Erlotiniblet), you can ask a Health Expert or Ask Patient Community about Erlotiniblet).
Erlotiniblet) Side Effects Report #5444139-0
Physician from UNITED STATES reported ERLOTINIBLET) problem on Aug 17, 2007. Male patient, 81 years of age, weighting 142.2 lb, was diagnosed with non-small cell lung cancer and was treated with ERLOTINIBLET). After drug was administered, patient experienced the following problems/side effects: anorexia, asthenia, blood calcium decreased, blood chloride increased, blood creatinine increased, blood urea increased, dehydration, fatigue, hypernatraemia. ERLOTINIBLET) dosage: 150 MG, ORAL. During the same period patient was treated with BEVACIZUMAB, PEMETREXED, INDAPAMIDE, LISINOPRIL, TERAZOSIN, POTASSIUM CHLORIDE, VITAMIN B12, FOLIC ACID. Patient was hospitalized. Patient recovered.
Erlotiniblet) Side Effects Report #5404265-9
ERLOTINIBLET) problem was reported by a Health Professional from UNITED STATES on July 16, 2007. Female patient, 71 years of age, weighting 181.0 lb, was diagnosed with oesophageal carcinoma and was treated with ERLOTINIBLET). After drug was administered, patient experienced the following problems/side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, leukopenia, mucosal inflammation, neutrophil count decreased, protein total decreased, pyrexia. ERLOTINIBLET) dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.
Erlotiniblet) Side Effects Report #5404265-9
Health Professional from UNITED STATES reported ERLOTINIBLET) problem on July 16, 2007. Female patient, 71 years of age, weighting 181.0 lb, was diagnosed with oesophageal carcinoma and was treated with ERLOTINIBLET). After drug was administered, patient experienced the following problems/side effects: blood chloride decreased, blood glucose increased, blood sodium decreased, diarrhoea, leukopenia, mucosal inflammation, neutrophil count decreased, protein total decreased, pyrexia. ERLOTINIBLET) dosage: 100 MG. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.